Optimizing Humanized Model Selection for Enhanced Preclinical Immunotherapy Assessment – FierceBiotech
FierceBiotech |
Optimizing Humanized Model Selection for Enhanced Preclinical Immunotherapy Assessment
FierceBiotech It's impossible to miss the ground-breaking impact immunotherapy has had on oncology research and patient outcomes. From the “coming of age” of the treatment modality, through multiple checkpoint inhibitor approvals across a variety of indications, to … |
